FindTrial
Sign In

Establishment of a Neuroendocrine Tumor Cohort and Exploration of Its Clinicopathological Characteristics

Establishment of a Neuroendocrine Tumor Cohort and Exploration of Its Clinicopathological Characteristics

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500096402
Enrollment
Unknown
Registered
2025-01-23
Start date
2025-01-29
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neuroendocrine neoplasms

Interventions

None:None

Sponsors

Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age is not limited, both men and women can be included; 2. Patients diagnosed with neuroendocrine tumors through histological or cytological analysis; 3. Acceptance or non acceptance of surgery, chemotherapy, radiotherapy, local treatment, or traditional Chinese medicine treatment for tumors is acceptable;

Exclusion criteria

Exclusion criteria: Those who cannot be diagnosed by pathology.

Design outcomes

Primary

MeasureTime frame
Overall Survival, OS;—

Secondary

MeasureTime frame
Progression-Free Survival, PFS;Disease-free survival,DFS;Objective Response Rate, ORR;Disease Control Rate, DCR;—

Countries

China

Contacts

Public ContactXiao Xiuying/Xiong Hua

Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine

xiaoxiuying2002@163.com+86 135 6457 9313

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026